Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


A peptide antagonist disrupts NK cell inhibitory synapse formation.

Borhis G, Ahmed PS, Mbiribindi B, Naiyer MM, Davis DM, Purbhoo MA, Khakoo SI.

J Immunol. 2013 Mar 15;190(6):2924-30. doi: 10.4049/jimmunol.1201032. Epub 2013 Feb 4.


Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase.

Lau A, Swinbank KM, Ahmed PS, Taylor DL, Jackson SP, Smith GC, O'Connor MJ.

Nat Cell Biol. 2005 May;7(5):493-500. Epub 2005 Apr 17.


Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].

Taylor DL, Ahmed PS, Tyms AS, Wood LJ, Kelly LA, Chambers P, Clarke J, Bedard J, Bowlin TL, Rando RF.

Antivir Chem Chemother. 2000 Jul;11(4):291-301.


Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2'-deoxy-3'-oxa-4'-thiocytidine.

de Muys JM, Gourdeau H, Nguyen-Ba N, Taylor DL, Ahmed PS, Mansour T, Locas C, Richard N, Wainberg MA, Rando RF.

Antimicrob Agents Chemother. 1999 Aug;43(8):1835-44.


Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.

Taylor DL, Ahmed PS, Chambers P, Tyms AS, Bedard J, Duchaine J, Falardeau G, Lavallée JF, Brown W, Rando RF, Bowlin T.

Antivir Chem Chemother. 1999 Mar;10(2):79-86.


MDL 74,968, a new acyclonucleotide analog: activity against human immunodeficiency virus in vitro and in the hu-PBL-SCID.beige mouse model of infection.

Bridges CG, Taylor DL, Ahmed PS, Brennan TM, Hornsperger JM, Navé JF, Casara P, Tyms AS.

Antimicrob Agents Chemother. 1996 May;40(5):1072-7.

Supplemental Content

Loading ...
Support Center